Ramat Gan, Israel Wednesday, November 5, 2025, 12:00 Hrs [IST] ...
TScan Therapeutics reaches agreement with US FDA on pivotal study design for TSC-101 and announces strategic prioritization to advance TSC-101: Waltham, Massachusetts Wednesday, N ...
AmacaThera inks global licensing agreement with Pacira BioSciences for up to US$ 230 mn, validating its tunable drug delivery platform: Toronto, Ontario Wednesday, November 5, 202 ...
Intas Pharma solidifies top 6 rank with double-digit growth in September 2025: Our Bureau, Chennai Wednesday, November 5, 2025, 17:40 Hrs [IST] Ahmedabad-based Intas Pharmaceutica ...
Peethaambaran Kunnathoor, Chennai Wednesday, November 5, 2025, 08:00 Hrs [IST] ...
Do you offer a dedicated single point of contact for the entire permitting process? Can you provide specific examples of how you have helped other pharma or healthcare companies expedite their ...
Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation: Our Bureau, Chennai Wednesday, November 5, 2025, 13:50 Hrs [IST] Pharmaceutica ...
Mumbai EOW initiates probe against Medikabazaar current board members and partners for corporate fraud: Our Bureau, Mumbai Wednesday, November 5, 2025, 16:15 Hrs [IST] The Economi ...
Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb: Rahway, New Jersey Wednesd ...
RDIF to promote pharma, medical devices research by private sector: Our Bureau, New Delhi Wednesday, November 5, 2025, 08:00 Hrs [IST] Research by private firms in the field of ph ...
APPC announces election schedule to elect six members to the council: Peethaambaran Kunnathoor, Chennai Wednesday, November 5, 2025, 08:00 Hrs [IST] The office of the returning of ...
ICMR invites EoI from companies for development, manufacturing of mAbs against Nipah virus: Shardul Nautiyal, Mumbai Wednesday, November 5, 2025, 08:00 Hrs [IST] The Indian Counci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results